We enable longer and healthier living through detection and monitoring of serious disease

At Chembio, our mission is to be a leader in the development, manufacture and commercialization of diagnostic solutions. We are dedicated to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). As a global company, we are committed to innovation and the highest quality standards.

At the core of our commitment is our patented Next Generation DPP® (Dual Path Platform) technology. Our DPP® technology is a breakthrough in POC diagnostics, offering significant advantages over lateral-flow technologies including:

Significantly improved sensitivity

Multiplexing – multiple test results via a single blood sample (e.g., HIV-Syphilis Assay)

Application in a number of indications

Today our DPP® technology is the basis of multiple collaborations with healthcare innovators and leaders worldwide spanning infectious diseases such as HIV, Zika, Ebola, syphilis, malaria and febrile illness, as well as potential new uses in the diagnosis of a specific form of cancer and brain injury (concussion).

Company Growth (employees)
Medford, US
Size (employees)
131 (est)
Chembio was founded in 1986 and is headquartered in Medford, US

Chembio Office Locations

Chembio has an office in Medford
Medford, US (HQ)
3661 Horseblock Road

Chembio Financials and Metrics

Chembio Financials

Chembio's revenue was reported to be $17.9 m in FY, 2016

Revenue (Q2, 2017)

4.1 m

Gross profit (Q2, 2017)

1.9 m

Gross profit margin (Q2, 2017), %


Net income (Q2, 2017)

(2.2 m)

EBIT (Q2, 2017)

(2.2 m)

Market capitalization (11-Dec-2017)

5.1 m

Cash (30-Jun-2017)

3.7 m
Chembio's current market capitalization is $5.1 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


29.5 m27.6 m24.3 m17.9 m

Revenue growth, %


Cost of goods sold

17.2 m16.8 m13.8 m9.4 m

Gross profit

12.3 m10.8 m10.5 m8.5 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


9.6 m5.8 m7.4 m7.3 m6.2 m6.7 m6.9 m6.6 m3.3 m3.7 m6.3 m4.1 m

Cost of goods sold

5.6 m3.5 m4.4 m4.7 m3.5 m3.7 m4 m3.4 m1.7 m1.8 m3.2 m2.2 m

Gross profit

4.1 m2.3 m3 m2.7 m2.7 m3 m2.9 m3.2 m1.6 m2 m3.1 m1.9 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


9.7 m4.6 m5.4 m10.6 m

Accounts Receivable

525.6 m


3.2 m3.6 m3.6 m3.3 m

Current Assets

18.5 m17.7 m12.6 m18.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


8 m9.1 m6.8 m3.7 m2.8 m1.6 m1.1 m2.7 m1.4 m12.2 m5.6 m3.7 m


3.7 m3.6 m4.1 m4 m3.7 m3.8 m3 m3.4 m3.5 m3.4 m3.8 m5 m

Current Assets

18 m17.2 m17.5 m17 m16.2 m15.7 m15.2 m12 m10.4 m20.6 m15.9 m14.1 m


1.8 m1.9 m2.1 m2.1 m3 m2.8 m2.6 m2.2 m2 m1.8 m1.9 m2.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

530.8 k(1.1 m)(2.4 m)(13.3 m)

Depreciation and Amortization

607.8 k739.3 k1.4 m1.1 m

Accounts Receivable

263.2 k(3.8 m)5.9 m(960.8 k)


(700.7 k)(449.6 k)60.3 k242.8 k
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

716.7 k(224.7 k)(146 k)(270.6 k)(303.6 k)(8.3 m)(2.1 m)(1.6 m)


4.1 m4 m3.7 m3.8 m3 m3.4 m3.5 m3.4 m3.8 m
Y, 2017

Financial Leverage

1.3 x
Show all financial metrics

Chembio Operating Metrics

FY, 2016

Patents (US)



Show all operating metrics

Chembio Market Value History

Chembio Revenue Breakdown

Chembio's Web-traffic and Trends

Chembio Online and Social Media Presence

Chembio Company Life and Culture

You may also be interested in